Obesity Management Market Already Demonstrates Growth Potential: Prognostications Up To 2022
Obesity Management Market Information, by Prescription; by Surgery; by Lifestyle changes - Forecast to 2022
(EMAILWIRE.COM, October 28, 2017 ) Obesity management Market is growing moderately. Changing lifestyle and unhealthy eating habits are leading to the problem of obesity. The population of obese people are increasing globally. Obesity leads to various diseases such as diabetes, hypertension, heart diseases and many others. Drugs manufacturers investing their money in R&D to develop effective anti-obesity drugs. However, several side effects of drugs, regulatory issues and high cost are the major restraints for the market.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2690.
Obesity Management Market is expected to grow at the average CAGR of 8.4% during 2015-2022. Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015.
Companies Involved:
Some of the key players in this market are: Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)
Market Segments:
On the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others.
On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others.
On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.
Regional Analysis of Obesity Management Market:
Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient.
Considering the global scenario of the market, North America region is believed to be the largest market for Obesity management. Moreover the European market is also growing and second largest market for Obesity management. On the other hand, Asia-Pacific market is expected to grow at significant rate in the Obesity management during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.
Browse Report @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690 .
Table of Content:
Report Prologue
Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Obesity Management Market By Prescription Weight-Loss
Medication
Global Obesity Management Market By Surgery
Global Obesity Management Market By End User
Global Obesity Management Market By Region
LIST OF TABLES
TABLE 1 GLOBAL OBESITY MANAGEMENT MARKET BY PRESCRIPTION WEIGHT-LOSS MEDICATION
TABLE 2 GLOBAL OBESITY MANAGEMENT MARKET BY SURGERY
TABLE 3 GLOBAL OBESITY MANAGEMENT MARKET BY END USER
TABLE 4 GLOBAL OBESITY MANAGEMENT MARKET BY REGION
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2690.
Obesity Management Market is expected to grow at the average CAGR of 8.4% during 2015-2022. Obesity management Market is expected to reach US$ 6.2 billion by 2022 from US$ 4.17 billion in 2015.
Companies Involved:
Some of the key players in this market are: Pfizer Inc. (US), Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GlaxoSmithKline plc. (UK), AstraZeneca (UK), Herbalife Ltd. (U.S.), Apollo Endosurgery (U.S.), Ethicon, Inc. (U.S.)
Market Segments:
On the basis of Prescription weight-loss medication which comprise orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), buproprion and naltrexone (Contrave), and liraglutide (Saxenda), and others.
On the basis of Surgery it segmented into Gastric bypass surgery, Laparoscopic adjustable gastric banding (LAGB), Biliopancreatic diversion with duodenal switch, and others.
On the basis of lifestyle changes it is segmented into Dietary changes, Exercise, and others.
Regional Analysis of Obesity Management Market:
Earlier obesity was considered as problem of high income countries but now it’s shifting towards low-middle income countries. Healthcare solution providers are developing new and innovative solutions for healthcare sector. Hospitals also providing different surgery options according to medical history and condition of the patient.
Considering the global scenario of the market, North America region is believed to be the largest market for Obesity management. Moreover the European market is also growing and second largest market for Obesity management. On the other hand, Asia-Pacific market is expected to grow at significant rate in the Obesity management during the forecasted period. Rest of the World is likely to have a limited but steady growth in the market.
Browse Report @ https://www.marketresearchfuture.com/reports/obesity-management-market-2690 .
Table of Content:
Report Prologue
Introduction
Research Methodology
Market Dynamics
Market Factor Analysis
Global Obesity Management Market By Prescription Weight-Loss
Medication
Global Obesity Management Market By Surgery
Global Obesity Management Market By End User
Global Obesity Management Market By Region
LIST OF TABLES
TABLE 1 GLOBAL OBESITY MANAGEMENT MARKET BY PRESCRIPTION WEIGHT-LOSS MEDICATION
TABLE 2 GLOBAL OBESITY MANAGEMENT MARKET BY SURGERY
TABLE 3 GLOBAL OBESITY MANAGEMENT MARKET BY END USER
TABLE 4 GLOBAL OBESITY MANAGEMENT MARKET BY REGION
Contact Information:
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Marketresearchfuture
Market Research Future
Tel: +1 (646) 845 9349
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results